Skip to main content
. 2023 Jan 16;11(1):228. doi: 10.3390/biomedicines11010228
PD Parkinson’s disease
SNpc substantia nigra pars compacta
PFC prefrontal cortex
LCD Licochalcone D
iPSCs induced pluripotent stem cells
pNSCs primitive neural stem cells
LRRK2 leucine-rich repeat kinase 2
Lk2GS LRRK2 G2019S
ROS reactive oxygen species
PAX6 paired box 6
SOX2 SRY-box transcription factor 2
NES Nestin
cCASP3 cleaved caspase-3
MAPK mitogen-activated protein kinase
EGFR epidermal growth factor receptor
AKT serine/thereonine protein kinase B
JNK c-Jun NH(2)-terminal kinases
PARP poly (ADP-ribose) polymerase
PI3K phosphoinositide 3-kinase
mTOR mechanistic target of rapamycin
BBB blood–brain barrier